SecurityLCUT / Lifetime Brands, Inc. (53222Q103)
Institutional Owners99 (33 N-Q Owners)
Institutional Shares18,136,083 - 88.30% (ex. N-Q)
Common Shares Outstanding20,540,268 shares (as of 2017-12-31)
Institutional Value$ 166,832,000 USD (ex. N-Q)

Institutional Stock Ownership and Shareholders

Lifetime Brands, Inc. (NASDAQ:LCUT) has 99 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,136,083 shares. Largest shareholders include Taylor Parent, Llc, Mill Road Capital Management LLC, Mill Road Capital II, L.P., Wellington Management Group LLP, Wellington Trust Co NA, Dimensional Fund Advisors Lp, BlackRock Inc., Vanguard Group Inc, Northern Trust Corp, and Petrus Trust Company, LTA.

Lifetime Brands, Inc. (NASDAQ:LCUT) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-02-14 13F-HR GLG Partners LP 31,573 31,573 0.00 578 521 -9.86
2018-02-13 13F-HR ALLIANCEBERNSTEIN L.P. 10,100 0 -100.00 185 0 -100.00
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 45,932 44,459 -3.21 841 734 -12.72
2018-02-14 13F-HR Parallax Volatility Advisers, L.P. 1,470 24
2017-11-20 N-Q Royce Micro-cap Trust, Inc /md/ (see advisory)
2017-11-28 N-Q Usaa Mutual Funds Trust (see advisory)
2018-03-12 SC 13D/A Mill Road Capital II, L.P. 1,582,044 1,628,203 2.92
2018-02-28 N-Q Wisdomtree Trust (see advisory)
2018-01-30 13F-HR BESSEMER GROUP INC 13,200 15,300 15.91 242 252 4.13
2018-02-09 SC 13G/A DIMENSIONAL FUND ADVISORS LP 1,212,232 1,202,294 -0.82
2018-01-25 13F-HR FTB Advisors, Inc. 580 800 37.93 11 13 18.18
2017-11-09 13F-HR TFS CAPITAL LLC 22,677 0 -100.00 412 0 -100.00
2018-03-05 13F-HR/A-1 BNP PARIBAS ARBITRAGE, SA 1,069 3,209 200.19 19,563 52,948 170.65
2018-02-14 13F-HR Clearbridge Investments, LLC 3,346 3,422 2.27 61 56 -8.20
2018-02-14 13F-HR Summit Trail Advisors, Llc 50 1
2017-11-29 N-Q Vanguard Index Funds (see advisory)
2018-02-13 13F-HR Axa 58,938 74,805 26.92 1,079 1,234 14.37
2018-02-14 13F-HR Brandywine Global Investment Management, LLC 10,137 9,935 -1.99 186 164 -11.83
2018-01-17 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 34,499 38,563 11.78 632 637 0.79
2018-02-14 13F-HR MENTA CAPITAL LLC 19,198 0 -100.00 351 0 -100.00
2018-02-14 13F-HR Polar Asset Management Partners Inc. 85,267 170,000 99.37 1,560 2,805 79.81
2018-02-14 13F-HR VANGUARD GROUP INC 410,266 498,496 21.51 7,508 8,225 9.55
2018-03-09 SC 13D Taylor Parent, Llc 5,593,116
2017-10-26 13F-HR Acrospire Investment Management LLC 2,344 0 -100.00 43 0 -100.00
2018-02-08 13F-HR FIRST TRUST ADVISORS LP 10,875 179
2018-02-08 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 8,279 8,464 2.23 152 139 -8.55
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 1,751 1,498 -14.45 32 25 -21.87
2017-10-27 N-Q Stone Ridge Trust (see advisory)
2017-10-30 N-Q Oppenheimer Global Multi Strategies Fund (see advisory)
2018-02-14 13F-HR TEACHERS ADVISORS INC 17,176 16,731 -2.59 314 276 -12.10
2018-02-15 13F-HR MARTIN & CO INC /TN/ 71,623 108,871 52.01 1,311 1,796 36.99
2018-04-13 13F-HR BANK OF MONTREAL /CAN/ 314 1,314 318.47 5 16 220.00
2018-02-09 13F-HR BARROW HANLEY MEWHINNEY & STRAUSS LLC 45,776 43,014 -6.03 838 710 -15.27
2018-02-08 SC 13G/A Wellington Trust Co NA 1,255,779 1,244,182 -0.92
2018-02-14 13F-HR BARCLAYS PLC 297 1,627 447.81 5 27 440.00
2018-02-14 13F-HR Ameritas Investment Partners, Inc. 858 858 0.00 14 14 0.00
2018-02-28 N-Q Gps Funds I (see advisory)
2018-02-13 13F-HR Legal & General Group Plc 2,271 2,271 0.00 42 38 -9.52
2018-02-01 13F-HR ALGERT GLOBAL LLC 78,708 0 -100.00 1,440 0 -100.00
2018-02-12 13F-HR CITIGROUP INC 9,404 13,645 45.10 172 225 30.81
2018-02-13 13F-HR Renaissance Technologies LLC 184,896 165,275 -10.61 3,384 2,727 -19.41
2017-11-29 N-Q Deutsche Investments Vit Funds (see advisory)
2017-11-13 13F-HR EAGLE GLOBAL ADVISORS LLC 19,202 0 -100.00 349 0 -100.00
2018-02-14 13F-HR DEUTSCHE BANK AG\ 53,575 61,073 14.00 979 1,007 2.86
2018-02-13 13F-HR JP Morgan Chase & Co 376,800 374,137 -0.71 7,046 6,174 -12.38
2017-11-14 13F-HR CORNERCAP INVESTMENT COUNSEL INC 36,320 0 -100.00 659 0 -100.00
2018-02-12 13F-HR MARTINGALE ASSET MANAGEMENT L P 39,911 42,507 6.50 731 702 -3.97
2018-01-26 N-Q Rbb Fund, Inc. (see advisory)
2018-02-14 13F-HR ROYAL BANK OF CANADA 27,059 26,200 -3.17 495 432 -12.73
2017-11-08 13F-HR Dynamic Technology Lab Private Ltd 10,513 0 -100.00 191 0 -100.00
2018-02-14 13F-HR/A-1 PUTNAM INVESTMENTS LLC 57,248 0 -100.00 1,048 0 -100.00
2018-04-10 SC 13G/A Wellington Management Group LLP 1,854,638 1,539,751 -16.98
2018-04-18 13F-HR CLARK ESTATES INC/NY 133,884 90,592 -32.34 2,209 1,123 -49.16
2018-02-14 13F-HR Mill Road Capital Management LLC 1,374,681 1,628,203 18.44 19,218 26,865 39.79
2018-02-13 13F-HR Delpha Capital Management, Llc 177 3
2018-03-01 N-Q Vericimetry Funds (see advisory)
2018-02-14 13F-HR Stone Ridge Asset Management LLC 17,596 290
2018-02-02 13F-HR MEEDER ASSET MANAGEMENT INC 0 11 0 0
2018-02-09 13F-HR AMERICAN INTERNATIONAL GROUP INC 6,535 6,675 2.14 120 110 -8.33
2017-11-28 N-Q Olstein Funds (see advisory)
2018-02-01 13F-HR Nationwide Fund Advisors 83,592 0 -100.00 1,530 0 -100.00
2018-02-14 13F-HR CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 18,178 10,078 -44.56 331 165 -50.15
2018-02-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 15,824 15,619 -1.30 290 258 -11.03
2018-02-28 N-Q Ishares Trust (see advisory)
2017-11-13 13F-HR OBERWEIS ASSET MANAGEMENT INC/ 35,800 0 -100.00 650 0 -100.00
2018-02-14 13F-HR BOKF, NA 7,734 0 -100.00 142 0 -100.00
2018-02-13 13F-HR GEODE CAPITAL MANAGEMENT, LLC 93,332 95,174 1.97 1,707 1,570 -8.03
2017-11-22 N-Q Bridgeway Funds Inc (see advisory)
2018-02-14 13F-HR PANAGORA ASSET MANAGEMENT INC 35 35 0.00 1 1 0.00
2018-02-28 N-Q Rydex Dynamic Funds (see advisory)
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 19,238 19,692 2.36 351 325 -7.41
2018-02-28 N-Q Seasons Series Trust (see advisory)
2017-11-28 N-Q Columbia Funds Variable Insurance Trust (see advisory)
2017-11-29 N-Q Vanguard Institutional Index Funds (see advisory)
2018-02-09 13F-HR Bank of New York Mellon Corp 93,250 94,607 1.46 1,707 1,561 -8.55
2017-11-14 13F-HR MILLENNIUM MANAGEMENT LLC 11,046 0 -100.00 200 0 -100.00
2017-11-29 N-Q Vanguard Valley Forge Funds (see advisory)
2018-02-12 13F-HR Pacific Ridge Capital Partners, LLC 267,441 276,131 3.25 4,894 4,556 -6.91
2018-02-08 13F-HR Olstein Capital Management, L.P. 144,263 150,481 4.31 2,640 2,483 -5.95
2018-02-13 13F-HR ClariVest Asset Management LLC 36,810 36,779 -0.08 674 607 -9.94
2018-02-28 N-Q Rydex Series Funds (see advisory)
2018-02-28 N-Q Franklin Templeton Etf Trust (see advisory)
2018-02-14 13F-HR Invesco Ltd. 20,628 17,504 -15.14 377 289 -23.34
2018-02-06 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 25,600 25,600 0.00 468 422 -9.83
2017-11-27 N-Q State Farm Mutual Fund Trust (see advisory)
2018-02-14 13F-HR UBS Group AG 615 1,698 176.10 11 28 154.55
2018-02-09 13F-HR BlackRock Inc. 733,309 738,439 0.70 13,420 12,184 -9.21
2018-01-23 13F-HR RICE HALL JAMES & ASSOCIATES, LLC 132,354 129,393 -2.24 2,422 2,135 -11.85
2017-11-29 N-Q First Trust Exchange-traded Fund (see advisory)
2017-11-28 N-Q Putnam Variable Trust (see advisory)
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 9,800 9,800 0.00 179 162 -9.50
2018-02-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 166,899 179,599 7.61 3,054 2,963 -2.98
2018-02-14 13F-HR NORTHERN TRUST CORP 493,756 491,303 -0.50 9,036 8,106 -10.29
2018-02-14 13F-HR MORGAN STANLEY 23,188 33,664 45.18 425 555 30.59
2017-11-08 N-Q Forum Funds Ii (see advisory)
2018-02-14 13F-HR Petrus Trust Company, LTA 480,000 480,000 0.00 8,784 7,920 -9.84
2018-02-08 13F-HR SEI INVESTMENTS CO 10 0 -100.00 0 0
2018-02-12 13F-HR RAMSEY QUANTITATIVE SYSTEMS 10,520 174
2018-02-14 13F-HR STATE STREET CORP 179,996 184,750 2.64 3,293 3,047 -7.47
2018-02-09 13F-HR Royce & Associates LLC 119,294 119,294 0.00 2,183 1,968 -9.85
2018-02-09 13F-HR RHUMBLINE ADVISERS 12,035 0 -100.00 220 0 -100.00
2017-11-27 N-Q State Farm Variable Product Trust (see advisory)
2018-02-27 N-Q Northern Funds (see advisory)
2018-01-29 N-Q Consulting Group Capital Markets Funds (see advisory)
2018-02-27 N-Q Blackstone Alternative Investment Funds (see advisory)
2018-01-26 N-Q Fidelity Concord Street Trust (see advisory)
2018-02-12 13F-HR AMERIPRISE FINANCIAL INC 237,400 238,700 0.55 4,344 3,938 -9.35
2018-01-25 N-Q Putnam Investment Funds (see advisory)
2017-11-22 N-Q Tiaa Separate Account Va 1 (see advisory)
2018-02-27 N-Q Massmutual Select Funds (see advisory)
2018-02-23 N-Q Rbc Funds Trust (see advisory)
2018-02-08 13F-HR MUFG Americas Holdings Corp 76 47 -38.16 1 1 0.00
2018-01-31 13F-HR WEDGE CAPITAL MANAGEMENT L L P/NC 55,250 0 -100.00 1,011 0 -100.00
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 16,441 22,434 36.45 301 370 22.92
2017-11-09 13F-HR NORDEA INVESTMENT MANAGEMENT AB 12,100 0 -100.00 220 0 -100.00
2017-11-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 12,603 0 -100.00 229 0 -100.00
2018-01-23 13F-HR STRS OHIO 33,500 33,500 0.00 613 552 -9.95

Form N-Q Advisory - Experimental Feature Here!

We have recently started to include coverage of N-Q filers in our ownership database. N-Q forms are unstructured and difficult for machines to parse into accurate financial data.

However, Because of the large number of these institutions and this difficulty in tracking their positions, they represent a significant, yet hidden, market force. In an effort to widen our ownership coverage and provide greater transparency, we are testing various ways to expose these owners in an accurate manner. This early version of the crawler simply identifies mentions of companies in the N-Q forms.

Limitations:

  • We only list underlying securities (the ordinary shares), even though the actual security held might be a derivative or a related bond issue. For example, although the institution is shown on this security page ( LCUT / Lifetime Brands, Inc. ), the institution may actually own a related security such as a preferred share or a bond. To find out the exact security, click on the institution link and then follow the link to the actual "N-Q".
  • We only list fund sponsors as institutions, even though the security might be held within a fund operated by the listed institution.. For example, the institution listed in the table as the owner is probably a sponsor of a family of ETFs or mutual funds. If so, then this security is owned by a fund or several funds within the family, and not directly owned by the listed institution. The crawler is not yet able to place these holdings within the individual funds. Atain, you must review the actual filing to see the detail.

These limitations are significant but we believe that the increased transparency outweights the limitations. Future revisions of the crawler will resolve these limitations. Use this information at your own risk!

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 53222Q103